PyInvesting

Market research

OCC.AU Orthocell Limited

AU AUD Healthcare

Latest close

0.57 —

As of Nov 20, 2026

Test a moving-average rule with historical data.

Market facts

Market cap
158M
P/E ratio
Not available
Analyst target
0.9
Dividend yield
Not available
Beta
-0.02

Community

Investor discussion

1 comment

Admin profile picture
Admin

Apr 1, 2021

Orthocell Limited is currently in a long term uptrend where the price is trading 18.8% above its 200 day moving average.

From a valuation standpoint, the stock is 57.4% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 109.7.

Orthocell Limited's total revenue rose by 57.7% to $637K since the same quarter in the previous year.

Its net income has dropped by 110.6% to $-4M since the same quarter in the previous year.

Finally, its free cash flow grew by 37.4% to $-2M since the same quarter in the previous year.

Based on the above factors, Orthocell Limited gets an overall score of 4/5.